Evidence map›Paper›PMID 22463890›Full record

Trial reportJournal of the American College of Surgeons2012

Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.

Laura J Porro, David N Herndon, Noe A Rodriguez, Kristofer Jennings, Gordon L Klein, Ronald P Mlcak, Walter J Meyer, Jong O Lee, Oscar E Suman, Celeste C Finnerty

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American College of Surgeons, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Predictors of muscle protein synthesis after severe pediatric burns.The journal of trauma and acute care surgery · 2015
    Trial
  11. Trial
  12. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.Journal of burn care & research : official publication of the American Burn Association
    Trial
  13. Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned Patients.Journal of burn care & research : official publication of the American Burn Association
    Trial
  14. Review
  15. Review
  16. Persistent inflammation, immunosuppression, and catabolism syndrome and sepsis in pediatric burns.Burns : journal of the International Society for Burn Injuries · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Laura J PorroShriners Hospitals for Children-Galveston, Galveston, TX 77550, USA.
David N Herndon
Noe A Rodriguez
Kristofer Jennings
Gordon L Klein
Ronald P Mlcak
Walter J Meyer
Jong O Lee
Oscar E Suman
Celeste C Finnerty
Shriners Hospitals for Children - Galveston · USThe University of Texas Medical Branch at Galveston · USShriners Hospitals for Children · US

Funding

Project 9: The role of androgen/corticosteroid in fat, muscle and glucose metabolism of burn victimsP50GM060338 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HERNDON, DAVID N. · 2000 to 2017
$24.2M
UTMB CLINICAL AND TRANSLATIONAL SCIENCE AWARD: NASA BED REST STUDIESUL1RR029876 · NCRR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2009 to 2011
$17.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
MODULATION OF THE POSTBURN HYPERMETABOLIC RESPONSER01GM056687 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HERNDON, DAVID N. · 1998 to 2017
$9.0M
Oxandrolone and Exercise: A potent therapy in the rehabilitation from burnsR01HD049471 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SUMAN-VEJAS, OSCAR E. · 2006 to 2019
$5.8M
POSTDOCTORAL TRAINING IN TRAUMA &BURNST32GM008256 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Celeste Campbell Finnerty, Oscar E. Suman-Vejas · 1990 to 2026
$4.0M
UTMB Clinical and Translational Science AwardKL2RR029875 · NCRR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2009 to 2011
$609k
NCATS NIH HHS UL1 TR000071NCRR NIH HHS KL2 RR029875NCRR NIH HHS KL2RR029875NCRR NIH HHS UL1 RR029876NCRR NIH HHS UL1RR029876NICHD NIH HHS R01 HD049471NICHD NIH HHS R01-HD049471NIGMS NIH HHS P50 GM060338NIGMS NIH HHS P50-GM60338NIGMS NIH HHS R01 GM056687NIGMS NIH HHS R01-GM56687-11S1NIGMS NIH HHS T32 GM008256NIGMS NIH HHS T32-GM8256PHS HHS H133A070026PHS HHS H133A70019
6 · The paper itself

Abstract

backgroundOxandrolone, an anabolic agent, has been administered for 1 year post burn with beneficial effects in pediatric patients. However, the long-lasting effects of this treatment have not been studied. This single-center prospective trial determined the long-term effects of 1 year of oxandrolone administration in severely burned children; assessments were continued for up to 4 years post therapy. STUDY

designPatients 0 to 18 years old with burns covering >30% of the total body surface area were randomized to receive placebo (n = 152) or oxandrolone, 0.1 mg/kg twice daily for 12 months (n = 70). At hospital discharge, patients were randomized to a 12-week exercise program or to standard of care. Resting energy expenditure, standing height, weight, lean body mass, muscle strength, bone mineral content (BMC), cardiac work, rate pressure product, sexual maturation, and concentrations of serum inflammatory cytokines, hormones, and liver enzymes were monitored.

resultsOxandrolone substantially decreased resting energy expenditure and rate pressure product, increased insulin-like growth factor-1 secretion during the first year after burn injury, and, in combination with exercise, increased lean body mass and muscle strength considerably. Oxandrolone-treated children exhibited improved height percentile and BMC content compared with controls. The maximal effect of oxandrolone was found in children aged 7 to 18 years. No deleterious side effects were attributed to long-term administration.

conclusionsAdministration of oxandrolone improves long-term recovery of severely burned children in height, BMC, cardiac work, and muscle strength; the increase in BMC is likely to occur by means of insulin-like growth factor-1. These benefits persist for up to 5 years post burn.

Indexed as

AdolescentAnabolic AgentsBiomarkersBody SizeBone DensityBurnsCalorimetry, IndirectChildChild, PreschoolCombined Modality TherapyEnergy MetabolismExercise TherapyFemaleFollow-Up StudiesHeartHumansAnabolic AgentsBiomarkersInsulin-Like Growth Factor IOxandrolone

Identifiers

PMID22463890
PMCPMC3412530
OpenAlexW2064393638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.